Triveni Bio
Develops novel antibody treatments for immunological and inflammatory disorders
$65MSeries C
Role not disclosedAV
Atlas Venture
Activity from announced rounds
All recorded activity
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $768M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in all activityKinaset Therapeutics
Develops inhaled therapies for severe respiratory diseases
$103MSeries B
Role not disclosedKailera Therapeutics
Kailera Therapeutics develops oral and injectable medicines for obesity using several GLP-1-based mechanisms.
$600MSeries B
Participant